“NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL”, Mediterr J Hematol Infect Dis, vol. 4, no. 1, p. e2012067, Oct. 2012, doi: 10.4084/mjhid.2012.067.